We are live on
!
Find out more
WE
Wealth Effects Portfolio holdings
AUM
$282M
1-Year Est. Return
62.81%
This Fund
S&P 500
This Quarter
Est. Return
+23.73%
1 Year Est. Return
+62.81%
3 Year Est. Return
+160.11%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$227M
AUM Growth
+$31.9M
(+16%)
Cap. Flow
-$1.77M
Cap. Flow
% of AUM
-0.78%
Top 10 Holdings %
Top 10 Hldgs %
46.5%
Holding
213
New
15
Increased
72
Reduced
78
Closed
11
Top Buys
| 1 |
SentinelOne
S
|
+$696K |
| 2 |
SEEL
Seelos Therapeutics, Inc. Common Stock
SEEL
|
+$604K |
| 3 |
Verizon
VZ
|
+$517K |
| 4 |
Meta Platforms (Facebook)
META
|
+$511K |
| 5 |
Impinj
PI
|
+$493K |
Top Sells
| 1 |
AVDL
Avadel Pharmaceuticals
AVDL
|
+$1.69M |
| 2 |
First Trust Exchange-Traded Fund IV First Trust Low Duration Opportunities ETF
LMBS
|
+$1.5M |
| 3 |
3D Systems Corp
DDD
|
+$471K |
| 4 |
Twilio
TWLO
|
+$465K |
| 5 |
Roundhill Ball Metaverse ETF
METV
|
+$441K |
Sector Composition
| 1 | Healthcare | 28.3% |
| 2 | Technology | 21.95% |
| 3 | Financials | 6.74% |
| 4 | Communication Services | 5.79% |
| 5 | Industrials | 5.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
IMDX
201
Insight Molecular Diagnostics
IMDX
$153M
| $9.31K | ﹤0.01% |
2,025
| – | – |
|
|
PVLA
202
Palvella Therapeutics
PVLA
$2.26B
| $2.76K | ﹤0.01% |
209
-69
| -25% | -$4.18K |
|
|
DVAX
203
DELISTED
Dynavax Technologies
DVAX
| – | – |
-27,250
| Closed | -$267K |
|
204
iShares Select Dividend ETF
DVY
$23.8B
| – | – |
-1,955
| Closed | -$229K |
|
|
FCT
205
First Trust Senior Floating Rate Income Fund II
FCT
$249M
| – | – |
-10,240
| Closed | -$102K |
|
206
Coca-Cola
KO
$351B
| – | – |
-3,250
| Closed | -$202K |
|
|
207
Roundhill Ball Metaverse ETF
METV
$215M
| – | – |
-2,080
| Closed | -$441K |
|
208
Annaly Capital Management
NLY
$16.9B
| – | – |
-10,125
| Closed | -$193K |
|
209
PayPal
PYPL
$49.9B
| – | – |
-3,843
| Closed | -$292K |
|
210
Regions Financial
RF
$27B
| – | – |
-18,438
| Closed | -$342K |
|
|
211
Twilio
TWLO
$31.4B
| – | – |
-6,985
| Closed | -$465K |
|
212
Viatris
VTRS
$20.1B
| – | – |
-15,132
| Closed | -$146K |
|
213
Yeti Holdings
YETI
$3.87B
| – | – |
-6,270
| Closed | -$251K |
|
Similar funds
SIC
DRD
II
3CP
MFG
TC
UFAC
TPW
Wealth Effects's Q2 2023 Portfolio in Review
As of Q2 2023, Wealth Effects held 213 positions worth $227M, up 16% from $195M the previous quarter. Its ten largest holdings account for 46% of the portfolio.
Wealth Effects's Q2 2023 filing shows 15 new, 72 increased, 78 reduced and 11 closed positions. Its largest new stake was Meta Platforms (Facebook): 2,070 shares worth $594K. The largest sale was Avadel Pharmaceuticals, an estimated $1.69M.
By sector, the portfolio is most concentrated in Healthcare at 28% of assets, up from 24% a quarter earlier, followed by Technology and Financials.
- Wealth Effects's largest Q2 2023 buy was Meta Platforms (Facebook): 2,070 shares worth $594K.
- Wealth Effects added most to SentinelOne in Q2 2023, an estimated $696K increase.
- Wealth Effects's biggest Q2 2023 reduction was Avadel Pharmaceuticals, cutting an estimated $1.69M.
- Wealth Effects fully exited Twilio in Q2 2023, selling an estimated $465K.
- Wealth Effects's ten largest holdings make up 46% of its $227M portfolio in Q2 2023.
- Wealth Effects opened 15 new positions and closed 11 in Q2 2023.
- Wealth Effects's portfolio value rose 16% quarter-over-quarter to $227M.
Based on Wealth Effects's 13F filing for Q2 2023, filed 18 Jul 2023.